On February 26, 2025, the European Chemicals Agency (ECHA) has updated its annual evaluation statistics. Since the implementation of the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation in 2009, ECHA has completed compliance checks on 15,500 chemical registration dossiers, covering 3,200 chemical substances (23% of all submitted dossiers). Among these, 34% of high-production-volume chemicals (with annual registrations exceeding 100 tonnes) have undergone compliance checks to ensure their safety data meets EU standards, safeguarding human health and the environment from risks.
Key Actions and Achievements in 2024
In 2024, ECHA conducted 313 compliance checks, covering nearly 2,000 registrations and 272 substances, with a focus on dossiers potentially lacking critical data. As a result, the agency issued 208 decisions requiring companies to provide additional data to clarify long-term impacts of chemicals on human health or the environment.
ECHA also reviewed 161 testing proposals and issued 92 decisions to ensure industry-proposed tests guarantee the safe use of substances.
For information requests sent to companies, ECHA verified compliance with REACH requirements. In 2024, evaluations of 241 substances were completed. Approximately 70% of companies provided the requested information to the agency. The remaining 30% were referred to EU member states for enforcement and follow-up.
Additionally, ECHA adopted three substance evaluation decisions prepared by EU member states, requiring companies to submit further data to assess hazards of potentially risky substances.
Overall Progress from 2009 to 2024
Based on compliance checks, testing proposal reviews, and substance evaluations, ECHA has issued over 4,400 decisions since 2009, covering more than 2,900 chemicals and involving 15,000 requests for supplementary information. These requests prioritize environmental safety and human health concerns.
ECHA’s collaboration with EU member states aims to ensure companies strictly comply with REACH obligations and provide reliable data. The Joint Action Plan for Evaluation (JAPE), launched in 2019 and completed in 2024, proposed multiple improvements. Future priorities include optimizing data submission processes and strengthening oversight of high-risk substances.
